Phthalic Acid

Phthalic Acid

SCHEMBL642600

O=C(O)c1ccccc1C(=O)O.[Co]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.93
ALOX15 P16050 1/20 0.93
AKR1C3 P42330 3/20 0.67
NAPRT Q6XQN6 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
HMGB1 P09429 1/20 0.65
HPGD P15428 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA7 P43166 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CA9 Q16790 1/20 0.65
CA14 Q9ULX7 1/20 0.65
MAPT P10636 2/20 0.62
HDAC8 Q9BY41 1/20 0.62
POLB P06746 1/20 0.59
NR4A1 P22736 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL29364035 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29674820 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL146125 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL10477086 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1808 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL8671920 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1686043 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL5668586 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL4452470 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1332278 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101510604-B Composite anode active material,method of preparing the same,and anode and lithium battery containing the material SAMSUNG SDI CO LTD 2012-11-21 CN claimed
US-8148014-B2 Composite anode active material, method of preparing the same, and anode and lithium battery containing the material SAMSUNG SDI CO., LTD. (KR) 2012-04-03 US claimed
EP-1959513-B1 Composite anode active material,method of preparing the same,and anode and lithium battery containing the material SAMSUNG SDI CO LTD (KR) 2009-10-21 EP claimed
CN-101510604-A Composite anode active material,method of preparing the same,and anode and lithium battery containing the material SAMSUNG SDI CO LTD (KR) 2009-08-19 CN claimed
US-20080199779-A1 includes a metal that may be alloyed with lithium, an intermetallic compound incapable of alloying with lithium, and a carbonaceous material, wherein the intermetallic compound exists in a phase structurally separated from the metal capable of alloying with lithium; improved charge and discharge SAMSUNG SDI CO., LTD. (KR) 2008-08-21 US claimed
EP-1959513-A1 Composite anode active material,method of preparing the same,and anode and lithium battery containing the material Samsung SDI Co., Ltd. (KR) 2008-08-20 EP claimed
US-20260074219-A1 CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERIES, METHOD OF PREPARING SAME, CATHODE INCLUDING THE SAME, AND LITHIUM SECONDARY BATTERY INCLUDING CATHODE SAMSUNG SDI CO., LTD. (KR) 2026-03-12 US disclosed
CN-115939331-A Positive electrode active material, method for preparing same, positive electrode comprising same, and lithium secondary battery 三星SDI株式会社 2023-04-07 CN disclosed
US-20230076517-A1 CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERIES, METHOD OF PREPARING SAME, CATHODE INCLUDING THE SAME, AND LITHIUM SECONDARY BATTERY INCLUDING CATHODE SAMSUNG SDI CO., LTD. (KR) 2023-03-09 US disclosed
US-20210275874-A1 GOLF BALL AND METHOD OF MAKING SAME ACUSHNET COMPANY (US) 2021-09-09 US disclosed
CN-107106463-B Acoustically activated cosmetic hydrogels 欧莱雅公司 2020-10-27 CN disclosed
CN-107108879-B Photoactivated hydrogels 欧莱雅公司 2020-06-05 CN disclosed
CN-106572957-B Skin color improving agent and composition for improving skin color 昭和电工株式会社 2020-03-27 CN disclosed
CN-87106234-A The low-molecular weight polymer of moisture-curable and composition thereof and mixture 1988-06-08 CN disclosed
US-4683257-A POLYBUTADIENE BLEND BRIDGESTONE CORPORATION (JP) 1987-07-28 US disclosed
US-4604296-A WASHING FERROMAGNETIC METAL FINE POWDER WITH SOLVENT FUJI PHOTO FILM CO., LTD. (JP) 1986-08-05 US disclosed
US-4379866-A Plugging refractory material having resin binder system GENERAL REFRACTORIES COMPANY (US) 1983-04-12 US disclosed
US-4189603-A CATALYTIC OXIDATION OF A P-DIALKULBENZENE IN PRESENCE OF A PHENOL AND ALIPHATIC CARBOXYLIC ACID SOLVENT MATSUYAMA PETROCHEMICALS INC. (JP) 1980-02-19 US disclosed
US-4098830-A OXIDATIVE COUPLING OF ALKYLPHENOLS OR 1-NAPHTHOLS CATALYZED BY METAL COMPLEXES OF DICARBOXYLIC ACID COMPOUNDS ICI AMERICAS INC. (US) 1978-07-04 US disclosed
US-4022739-A CLAY, AGGREGATE, HYDROCARBON BINDER TERRAC COMPANY LIMITED (GB) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260074219-A1 CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERIES, METHOD OF PREPARING SAME, CATHODE INCLUDING THE SAME, AND LITHIUM SECONDARY BATTERY INCLUDING CATHODE CACNA2D4, CACNA2D1, CACNA2D2 ALDH1A1 3332/4885ALOX15 3785/4885AKR1C3 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.